Literature DB >> 16392957

Effect of estrogen on radiation-induced cataractogenesis.

Joseph R Dynlacht1, Craig Tyree, Shailaja Valluri, Colleen DesRosiers, Andrea Caperell-Grant, Marc S Mendonca, Robert Timmerman, Robert M Bigsby.   

Abstract

Cataractogenesis is a widely reported late effect that is observed in patients receiving total-body irradiation (TBI) prior to bone marrow transplantation or radiotherapy for ocular or head and neck cancers. Recent studies indicate that estrogens may protect against age-related and drug-induced cataracts. Moreover, other reports suggest that estrogen possesses antioxidant properties. Since the effect of estrogen on radiation cataractogenesis is unknown, we wished to determine whether estrogen modulates radiation-induced opacification of the lens. Intact or ovariectomized Sprague-Dawley rats were treated with either 17-beta-estradiol or an empty silastic capsule. The right orbit was then irradiated with either 10 or 15 Gy of (60)Co gamma rays using a Leksell Gamma Knife, and lenses were examined at various times postirradiation with a slit lamp or evaluated for light transmission. We found that for ovariectomized rats irradiated with 15 Gy, the lens opacity and the incidence of cataract formation in the estradiol-treated group were significantly increased compared to the control group at the end of the 25-week period of observation. Cataract incidence was also high in irradiated eyes of ovary-intact animals at 25 weeks postirradiation but was greatly reduced in the ovariectomized control group, with less than half of irradiated eyes showing evidence of cataractogenesis. Thus, after irradiation with 15 Gy of gamma rays, estrogen increased the incidence of cataract formation. We also observed that although the incidence of cataract formation in rats irradiated with 10 Gy and receiving continuous estrogen treatment was not altered compared to rats in the control group that did not receive estrogen, the latent period for posterior subcapsular cataract formation decreased and the severity of the anterior cataract increased. Taken together, our data suggest that estrogen accelerates progression of radiation-induced opacification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392957     DOI: 10.1667/rr3481.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  High affinity nuclear and nongenomic estradiol binding sites in the human and mouse lens.

Authors:  M Rachel Kirker; Katie M Gallagher; Paula A Witt-Enderby; Vicki L Davis
Journal:  Exp Eye Res       Date:  2013-04-15       Impact factor: 3.467

2.  Estrogen protects against radiation-induced cataractogenesis.

Authors:  Joseph R Dynlacht; Shailaja Valluri; Jennifer Lopez; Falon Greer; Colleen Desrosiers; Andrea Caperell-Grant; Marc S Mendonca; Robert M Bigsby
Journal:  Radiat Res       Date:  2008-12       Impact factor: 2.841

3.  Interstrain differences in the development of pyometra after estrogen treatment of rats.

Authors:  Lisa Jane Brossia; Christopher Sean Roberts; Jennifer T Lopez; Robert M Bigsby; Joseph R Dynlacht
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-09       Impact factor: 1.232

4.  Risk of various types of cataracts in a cohort of Mayak workers following chronic occupational exposure to ionizing radiation.

Authors:  Tamara V Azizova; Nobuyuki Hamada; Evgeniya S Grigoryeva; Evgeny V Bragin
Journal:  Eur J Epidemiol       Date:  2018-10-10       Impact factor: 8.082

5.  Radioprotective effect of hesperidin on reducing oxidative stress in the lens tissue of rats.

Authors:  Navid Karimi; Ali Shabestani Monfared; Gholam Hassan Haddadi; Abbas Soleymani; Erfan Mohammadi; Karimollah Hajian-Tilaki; Sajad Borzoueisileh
Journal:  Int J Pharm Investig       Date:  2017 Jul-Sep

6.  Radioprotective effect of melatonin in reducing oxidative stress in rat lenses.

Authors:  Alireza Shirazi; Gholam Hasan Haddadi; Fahimeh Asadi-Amoli; Saeideh Sakhaee; Mahmoud Ghazi-Khansari; Abolghasem Avand
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.